The Emerging Facets of Non-Cancerous Warburg Effect

Alyaa M. Abdel‐Haleem, Nathan E. Lewis, Neema Jamshidi, Katsuhiko Mineta, Xin Gao, Takashi GojoboriFrontiers in Endocrinology 2017 · DOI

Abstract

The Warburg effect (WE), or aerobic glycolysis, is commonly recognized as a hallmark of cancer and has been extensively studied for potential anti-cancer therapeutics development. Beyond cancer, the WE plays an important role in many other cell types involved in immunity, angiogenesis, pluripotency, and infection by pathogens (e.g., malaria). Here, we review the WE in non-cancerous context as a "hallmark of rapid proliferation." We observe that the WE operates in rapidly dividing cells in normal and pathological states that are triggered by internal and external cues. Aerobic glycolysis is also the preferred metabolic program in the cases when robust transient responses are needed. We aim to draw attention to the potential of computational modeling approaches in systematic characterization of common metabolic features beyond the WE across physiological and pathological conditions. Identification of metabolic commonalities across various diseases may lead to successful repurposing of drugs and biomarkers.

Introduction

For decades, the "Warburg Effect" (WE) has been synonymous with cancer. It describes a metabolic shift where cells ferment glucose into lactate even when oxygen is plentiful—a process that yields significantly less ATP per glucose molecule than mitochondrial respiration. However, this "inefficient" metabolic program is not just a quirk of malignancy; it is a universal signature of rapid cell proliferation. By reframing the WE as a "hallmark of rapid proliferation," researchers can move beyond descriptive observations toward a systematic framework that explains why diverse cells converge on this strategy.

The Universal Nature of the Warburg Effect

The core insight of this perspective is that aerobic glycolysis is the preferred metabolic program for robust, transient responses. While oxidative phosphorylation (OxPhos) is more efficient for long-term energy stability, the WE provides the rapid biosynthetic precursors—such as nucleotides, lipids, and amino acids—needed for a cell to double its biomass quickly.

Contrary to Otto Warburg’s original 1950s hypothesis, mitochondria in these cells are often fully functional; the cell simply "chooses" to prioritize glycolysis to meet specific biosynthetic demands. This shift is observed across a spectrum of cells, from activated T-lymphocytes to malaria parasites.

The Warburg Effect as a hallmark of rapid proliferation across diverse cell types, showing the transition from quiescent to rapidly proliferating states.

Methodology: Constraint-Based Modeling

To move toward a systematic understanding, the authors propose a systems biology workflow centered on Constraint-Based Modeling (CBM) using Genome-Scale Metabolic Models (GEMs).

By integrating high-throughput "omics" data—including transcriptomics, proteomics, and fluxomics—into a unified CBM framework, researchers can simulate the metabolic "solution space" for different diseases. This comparative "metabolic convergence" workflow allows for the identification of essential metabolic nodes (like the enzyme PFKFB3) that are common across cancer, autoimmune disorders, and parasitic infections.

A systems biology workflow using constraint-based modeling to integrate multi-omics data and identify shared metabolic features across different cell types.

Key Findings across Domains

The WE manifests across several non-cancerous domains with striking consistency:

  • Immunity: Pro-inflammatory (M1) macrophages rely on the WE for rapid host defense, whereas anti-inflammatory (M2) macrophages prefer OxPhos for long-term tissue repair.
  • Angiogenesis: Proliferating endothelial cells derive up to 85% of their ATP from glycolysis, even in oxygen-rich blood.
  • Pluripotency: Stem cells utilize the WE to maintain their undifferentiated state and avoid oxidative stress (ROS) associated with mitochondrial respiration.
  • Infection: In the asexual stage of malaria (Plasmodium), glucose uptake increases 10-fold, mirroring the metabolic profile of aggressive cancer cells.

Future Outlook and Drug Repurposing

The identification of metabolic commonalities offers significant potential for drug repurposing. For instance, glycolysis-targeting drugs originally designed for cancer are showing promise in limiting pathological blood vessel growth.

However, a major hurdle remains the "therapeutic window." Suppressing the WE to treat a tumor might inadvertently impair healthy immune responses or wound healing. Future work must focus on developing "context-specific" metabolic models that can distinguish between the WE in beneficial contexts (like T-cell activation) versus pathological ones (like cancer or malaria) to identify truly selective therapeutic targets.

Summary updated

Abstract

The Warburg effect (WE), or aerobic glycolysis, is commonly recognized as a hallmark of cancer and has been extensively studied for potential anti-cancer therapeutics development. Beyond cancer, the WE plays an important role in many other cell types involved in immunity, angiogenesis, pluripotency, and infection by pathogens (e.g., malaria). Here, we review the WE in non-cancerous context as a "hallmark of rapid proliferation." We observe that the WE operates in rapidly dividing cells in normal and pathological states that are triggered by internal and external cues. Aerobic glycolysis is also the preferred metabolic program in the cases when robust transient responses are needed. We aim to draw attention to the potential of computational modeling approaches in systematic characterization of common metabolic features beyond the WE across physiological and pathological conditions. Identification of metabolic commonalities across various diseases may lead to successful repurposing of drugs and biomarkers.
BibTeX
@inproceedings{abdelhaleem2017emerging,
  author = {Alyaa M. Abdel‐Haleem and Nathan E. Lewis and Neema Jamshidi and Katsuhiko Mineta and Xin Gao and Takashi Gojobori},
  title = {{The Emerging Facets of Non-Cancerous Warburg Effect}},
  booktitle = {Frontiers in Endocrinology},
  year = {2017},
  doi = {10.3389/fendo.2017.00279},
}
Figure